Cellular and molecular mechanisms of atherosclerosis with mouse models

被引:38
作者
Ohashi, R
Mu, H
Yao, QH
Chen, CY
机构
[1] Baylor Coll Med, Michael E DeBakey Dept Surg, Div Vasc Surg & Endovasc Therapy, Houston, TX 77030 USA
[2] Baylor Coll Med, Mol Surg Res Ctr, Houston, TX 77030 USA
[3] Methodist Hosp, Houston, TX 77030 USA
关键词
D O I
10.1016/j.tcm.2004.04.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, there has been an explosion in the number of in vivo studies using genetically engineered mouse models. Atherosclerosis research using mice began with the invention of traditional atherosclerotic mice including low-density lipoprotein receptor knockout (LDLR-/-) and apolipoprotein E knockout (apoE(-/-)) mice, which provided tremendous progress in atherosclerosis research. Since then, a number of modified atherosclerotic mouse models have been reported to generate lesions that more closely characterize human atherosclerotic lesions. Those modifications include inflammation, hypertension, proteinases and extracellular matrix, glucose metabolism, and immune systems. This article focuses on various kinds of mouse models with athero-sclerosis and their contributions to the current advances of research. (C) 2004, Elsevier Inc.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 43 条
[1]   Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice [J].
Aiello, RJ ;
Bourassa, PAK ;
Lindsey, S ;
Weng, WF ;
Natoli, E ;
Rollins, BJ ;
Milos, PM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (06) :1518-1525
[2]   Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice [J].
Aiello, RJ ;
Bourassa, PA ;
Lindsey, S ;
Weng, WF ;
Freeman, A ;
Showell, HJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (03) :443-449
[3]   Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice [J].
Daugherty, A ;
Manning, MW ;
Cassis, LA .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1605-1612
[4]   The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/-mice [J].
Daugherty, A ;
Pure, E ;
DelfelButteiger, D ;
Chen, S ;
Leferovich, J ;
Roselaar, SE ;
Rader, DJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1575-1580
[5]  
Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205
[6]  
Emeson EE, 1996, AM J PATHOL, V149, P675
[7]   ROLE OF CYTOKINES IN INDUCING HYPERLIPIDEMIA [J].
FEINGOLD, KR ;
GRUNFELD, C .
DIABETES, 1992, 41 :97-101
[8]   Diabetes and atherogenesis [J].
Fisher, M .
HEART, 2004, 90 (03) :336-340
[9]   IMMUNE-DEFICIENT MICE DEVELOP TYPICAL ATHEROSCLEROTIC FATTY STREAKS WHEN FED AN ATHEROGENIC DIET [J].
FYFE, AI ;
QIAO, JH ;
LUSIS, AJ .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2516-2520
[10]   Specific abrogation of transforming growth factor-β signaling in T cells alters atherosclerotic lesion size and composition in mice [J].
Gojova, A ;
Brun, V ;
Esposito, B ;
Cottrez, F ;
Gourdy, P ;
Ardouin, P ;
Tedgui, A ;
Mallat, Z ;
Groux, H .
BLOOD, 2003, 102 (12) :4052-4058